Related references
Note: Only part of the references are listed.LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury
Peixing Wan et al.
CELL DEATH AND DIFFERENTIATION (2020)
Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway
Yan Jiang et al.
JOURNAL OF DRUG TARGETING (2020)
Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2020)
Comparison of foveal avascular zone and retinal vascular density in healthy Chinese and Caucasian adults
Adam Wylegala et al.
ACTA OPHTHALMOLOGICA (2020)
Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis
Yu Bian et al.
ACTA PHARMACOLOGICA SINICA (2020)
Calcium -Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis After Acute Myocardial Infarction via NLRP3 In flammasome Activation
Ziqi Ren et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension
Yin Kang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart
Anke C. Fender et al.
BASIC RESEARCH IN CARDIOLOGY (2020)
Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction
Gopalkrishna Sreejit et al.
CIRCULATION (2020)
VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis
Yiyi Li et al.
EXPERIMENTAL CELL RESEARCH (2020)
Isofraxidin Alleviates Myocardial Infarction Through NLRP3 Inflammasome Inhibition
Guofan Chen et al.
INFLAMMATION (2020)
M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway
Yuxiang Dai et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay
Huan Chen et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Antonio Abbate et al.
CIRCULATION RESEARCH (2020)
Microglia-Derived NLRP3 Activation Mediates the Pressor Effect of Prorenin in the Rostral Ventrolateral Medulla of Stress-Induced Hypertensive Rats
Li Hu et al.
NEUROSCIENCE BULLETIN (2020)
NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
Cheng Zeng et al.
REDOX BIOLOGY (2020)
NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Hui Chen et al.
MOLECULAR NEURODEGENERATION (2020)
Chronic cerebral hypoperfusion activates AIM2 and NLRP3 inflammasome
Hirofumi Matsuyama et al.
BRAIN RESEARCH (2020)
SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion
Ying Han et al.
REDOX BIOLOGY (2020)
Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion
Haining Wang et al.
LIFE SCIENCES (2020)
NLRP3 inflammasome via IL-1 13 regulates PCSK9 secretion
Zufeng Ding et al.
THERANOSTICS (2020)
SOD2 ameliorates pulmonary hypertension in a murine model of sleep apnea via suppressing expression of NLRP3 in CD11b+ cells
Cuiping Fu et al.
RESPIRATORY RESEARCH (2020)
Inhibition of GSK-3β alleviates cerebral ischemia/reperfusion injury in rats by suppressing NLRP3 inflammasome activation through autophagy
Yueting Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Magnus Back et al.
NATURE REVIEWS CARDIOLOGY (2019)
Inflammasome Activation Induces Pyroptosis in the Retina Exposed to Ocular Hypertension Injury
Alexey Pronin et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Nebivolol Improves Obesity-Induced Vascular Remodeling by Suppressing NLRP3 Activation
Jing Gao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
Hydrogen sulfide improves endothelial dysfunction by inhibiting the vicious cycle of NLRP3 inflammasome and oxidative stress in spontaneously hypertensive rats
Jiabao Li et al.
JOURNAL OF HYPERTENSION (2019)
IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation
Qd Ai et al.
TRANSLATIONAL RESEARCH (2019)
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Curcumin attenuates migration of vascular smooth muscle cells via inhibiting NFκB-mediated NLRP3 expression in spontaneously hypertensive rats
Ying Han et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)
NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice
Haining Wang et al.
LIFE SCIENCES (2019)
DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome
Yochai Birnbaum et al.
BASIC RESEARCH IN CARDIOLOGY (2019)
The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction
Rifeng Gao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Parkin-Dependent Mitophagy Is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats
Qi He et al.
CELLS (2019)
Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats
Minchun Zhang et al.
BMJ OPEN DIABETES RESEARCH & CARE (2019)
BRD4 suppression alleviates cerebral ischemia-induced brain injury by blocking glial activation via the inhibition of inflammatory response and pyroptosis
Yi Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway
Chongyang Ma et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension
Shalini M. Krishnan et al.
CARDIOVASCULAR RESEARCH (2019)
Selective Activation of Cannabinoid Receptor 2 Attenuates Myocardial Infarction via Suppressing NLRP3 Inflammasome
Wen Yu et al.
INFLAMMATION (2019)
Microglial Mincle receptor in the PVN contributes to sympathetic hyperactivity in acute myocardial infarction rat
Yu Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
IL-17A contributes to myocardial ischemic injury by activating NLRP3 inflammasome in macrophages through AMPKα/p38MAPK/ERK1/2 signal pathway in mice
Lisha Zhang et al.
MOLECULAR IMMUNOLOGY (2019)
Non-canonical Inflammasome-Mediated IL-1β Production by Primary Endometrial Epithelial and Stromal Fibroblast Cells Is NLRP3 and Caspase-4 Dependent
Paul Kelly et al.
FRONTIERS IN IMMUNOLOGY (2019)
SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome
Cristine J. Reitz et al.
COMMUNICATIONS BIOLOGY (2019)
Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
Fan Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
Wenqiang Gan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats
Ramoji Kosuru et al.
CARDIOVASCULAR DRUGS AND THERAPY (2018)
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Alena Grebe et al.
CIRCULATION RESEARCH (2018)
Biologics and Cardiovascular Disease
John S. Van Taunay et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
Cardioprotective Role of Colchicine Against Inflammatory Injury in a Rat Model of Acute Myocardial Infarction
Oussama Bakhta et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2018)
Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation
Hailong Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Fibronectin type III domain containing 5 attenuates NLRP3 inflammasome activation and phenotypic transformation of adventitial fibroblasts in spontaneously hypertensive rats
Li Ling et al.
JOURNAL OF HYPERTENSION (2018)
Central blockade of NLRP3 reduces blood pressure via regulating inflammation microenvironment and neurohormonal excitation in salt-induced prehypertensive rats
Mo-Lin Wang et al.
JOURNAL OF NEUROINFLAMMATION (2018)
IRE1 alpha inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats
Di Chen et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Paul M. Ridker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Dunye Guanxinning Improves Acute Myocardial Ischemia-Reperfusion Injury by Inhibiting Neutrophil Infiltration and Caspase-1 Activity
Q. G. Zhang et al.
MEDIATORS OF INFLAMMATION (2018)
Effects of Exercise on ASC Methylation and IL-1 Cytokines in Heart Failure
Brittany Butts et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2018)
Role of Brain Neuroinflammatory Factors on Hypertension in the Spontaneously Hypertensive Rat
Ennio Avolio et al.
NEUROSCIENCE (2018)
Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy
Kapka Miteva et al.
SCIENTIFIC REPORTS (2018)
The NLRP3-Caspase 1 Inflammasome Negatively Regulates Autophagy via TLR4-TRIF in Prion Peptide-Infected Microglia
Mengyu Lai et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury
Kai-Ying Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target
Teresa Pasqua et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Protective effects of α-bisabolol on altered hemodynamics, lipid peroxidation, and nonenzymatic antioxidants in isoproterenol-induced myocardial infarction: In vivo and in vitro evidences
Mohamed Fizur Nagoor Meeran et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)
Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury
Zhe Gong et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries (vol 392, pg 2203, 2018)
M. E. Kruk et al.
LANCET (2018)
Protection of Anthocyanin from Myrica rubra against Cerebral Ischemia-Reperfusion Injury via Modulation of the TLR4/NF-B and NLRP3 Pathways
Hong-Xin Cui et al.
MOLECULES (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Innate immune receptors over expression correlate with chronic chagasic cardiomyopathy and digestive damage in patients
Nathalie de Sena Pereira et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction
Qian Lei et al.
MEDICAL SCIENCE MONITOR (2018)
Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats
Qiu Huiliang et al.
PHYTOMEDICINE (2018)
Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection
Joseph Sarhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death
Pontus Orning et al.
SCIENCE (2018)
Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries
Margaret E. Kruk et al.
LANCET (2018)
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
Dongling Liu et al.
BASIC RESEARCH IN CARDIOLOGY (2018)
Interleukin-1 blockade for the treatment of pericarditis
Leo F. Buckley et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2018)
Mechanisms governing inflammasome activation, assembly and pyroptosis induction
Sannula Kesavardhana et al.
INTERNATIONAL IMMUNOLOGY (2017)
Role of NLRP3 Inflammasomes in Atherosclerosis
Tadayoshi Karasawa et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies
Matthew D. McGeough et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
Renqing Wang et al.
LABORATORY INVESTIGATION (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats
Zhen Qiu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension
Hai-Jian Sun et al.
CELL DEATH & DISEASE (2017)
T-lymphocyte Kv13 channel activation triggers the NLRP3 inflammasome signaling pathway in hypertensive patients
Jian Zhu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease
Li-Han Chin et al.
ONCOTARGET (2017)
Canonical and Non-Canonical Activation of NLRP3 inflammasome at the Crossroad between immune Tolerance and intestinal inflammation
Carolina Pellegrini et al.
FRONTIERS IN IMMUNOLOGY (2017)
NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling
Xing-Sheng Ren et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Could NLRP3-Inflammasome Be a Cardiovascular Risk Biomarker in Acute Myocardial Infarction Patients?
Pedro Bullon et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Role of P2X7R in the development and progression of pulmonary hypertension
Jie Yin et al.
RESPIRATORY RESEARCH (2017)
Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction
Koichiro Fujisue et al.
CIRCULATION JOURNAL (2017)
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
Yumei Ye et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
The cardioprotective effect of total flavonoids on myocardial ischemia/reperfusion in rats
Dongling Lv et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression
Rujun Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice
S. M. Krishnan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Targeting Interleukin-1 beta to Suppress Sympathoexcitation in Hypothalamic Paraventricular Nucleus in Dahl Salt-Sensitive Hypertensive Rats
Jie Qi et al.
CARDIOVASCULAR TOXICOLOGY (2016)
Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
Altaf Afrasyab et al.
HEART AND VESSELS (2016)
Pseudomonas aeruginosa Triggers Macrophage Autophagy To Escape Intracellular Killing by Activation of the NLRP3 Inflammasome
Qiuchan Deng et al.
INFECTION AND IMMUNITY (2016)
NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis
H. Chung et al.
CELL DEATH AND DIFFERENTIATION (2016)
Human Monocytes Engage an Alternative Inflammasome Pathway
Moritz M. Gaidt et al.
IMMUNITY (2016)
Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse
Stefano Toldo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence The AIRTRIP Randomized Clinical Trial
Antonio Brucato et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study
Benjamin W. Van Tassell et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Xing Liu et al.
NATURE (2016)
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
Yuan He et al.
NATURE (2016)
Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways
Raffaella Mastrocola et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways
Teneema Kuriakose et al.
SCIENCE IMMUNOLOGY (2016)
Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice
Fadila Telarevic Cero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins
Afrasyab Altaf et al.
CORONARY ARTERY DISEASE (2015)
NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5
Paul J. Baker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
The Importance of NLRP3 Inflammasome in Heart Failure
Brittany Butts et al.
JOURNAL OF CARDIAC FAILURE (2015)
Recent insights into the cellular biology of atherosclerosis
Ira Tabas et al.
JOURNAL OF CELL BIOLOGY (2015)
Internalized Cryptococcus neoformans Activates the Canonical Caspase-1 and the Noncanonical Caspase-8 Inflammasomes
Mingkuan Chen et al.
JOURNAL OF IMMUNOLOGY (2015)
Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
Xin Shi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
Jasna Klen et al.
JOURNAL OF DIABETES RESEARCH (2015)
Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
Xin Shi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
Allison C. Morton et al.
EUROPEAN HEART JOURNAL (2015)
A Tissue-Specific Role for Nlrp3 in Tubular Epithelial Repair after Renal Ischemia/Reperfusion
Pieter J. Bakker et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease
Lili Wang et al.
ARCHIVES OF MEDICAL SCIENCE (2014)
TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
Yi Liu et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
S. M. Krishnan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
Beibei Luo et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin
Mamoru Satoh et al.
CLINICAL SCIENCE (2014)
A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia-Reperfusion in the Mouse
Carlo Marchetti et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
NLRP3 Regulates Neutrophil Functions and Contributes to Hepatic Ischemia-Reperfusion Injury Independently of Inflammasomes
Yoshiyuki Inoue et al.
JOURNAL OF IMMUNOLOGY (2014)
FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes
Prajwal Gurung et al.
JOURNAL OF IMMUNOLOGY (2014)
Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
Fei Zheng et al.
MEDIATORS OF INFLAMMATION (2014)
Cardiovascular effects of statins, beyond lipid-lowering properties
Christos G. Mihos et al.
PHARMACOLOGICAL RESEARCH (2014)
Critical role for inflammasome-independent IL-1β production in osteomyelitis
John R. Lukens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Interaction of Inflammation, Hyperuricemia, and the Prevalence of Hypertension Among Adults Free of Metabolic Syndrome: NHANES 2009-2010
Eswar Krishnan
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth. University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
Yongliang Wang et al.
CARDIOLOGY (2013)
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemiareperfusion injury
Oystein Sandanger et al.
CARDIOVASCULAR RESEARCH (2013)
Treatment of Acute and Recurrent Idiopathic Pericarditis
Leonard S. Lilly
CIRCULATION (2013)
Association of nucleotide-binding oligomerization domain-like receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy
Beibei Luo et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β
Nathan A. Bracey et al.
EXPERIMENTAL PHYSIOLOGY (2013)
NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
Fei Zheng et al.
HEART LUNG AND CIRCULATION (2013)
Colchicine and the Heart Pushing the Envelope
Spyridon Deftereos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
NLRP3 promotes autophagy of urate crystals phagocytized by human osteoblasts
Isabelle Allaeys et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Regulation of HMGB1 release by inflammasomes
Ben Lu et al.
PROTEIN & CELL (2013)
NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
Hyun-Jung Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
Jessica Gage et al.
CANADIAN JOURNAL OF CARDIOLOGY (2012)
Right Ventricular Adaptation and Maladaptation in Chronic Pulmonary Arterial Hypertension
Stuart Rich
CARDIOLOGY CLINICS (2012)
Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension
David J. Ross et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome
Sonja I. Gringhuis et al.
NATURE IMMUNOLOGY (2012)
Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
Benjamin W. Van Tassell et al.
PLOS ONE (2012)
Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
Coert J. Zuurbier et al.
PLOS ONE (2012)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
Masanori Kawaguchi et al.
CIRCULATION (2011)
Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β
Nicolas Dupont et al.
EMBO JOURNAL (2011)
Inflammation, Immunity, and Hypertension
David G. Harrison et al.
HYPERTENSION (2011)
Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation
James Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
Kiichi Nakahira et al.
NATURE IMMUNOLOGY (2011)
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
Eleonora Mezzaroma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
Elaine Soon et al.
CIRCULATION (2010)
An Inflammasome-Independent Role for Epithelial-Expressed Nlrp3 in Renal Ischemia-Reperfusion Injury
Alana A. Shigeoka et al.
JOURNAL OF IMMUNOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria
Edward A. Miao et al.
NATURE IMMUNOLOGY (2010)
IL-1β Processing in Host Defense: Beyond the Inflammasomes
Mihai G. Netea et al.
PLOS PATHOGENS (2010)
Cardiac Fibroblast The Renaissance Cell
Colby A. Souders et al.
CIRCULATION RESEARCH (2009)
Ischemic-reperfusion syndromes: Biochemical and immunologic rationale for IL-1 targeted therapy
Alan A. Wanderer
CLINICAL IMMUNOLOGY (2008)
Subendothelial lipoprotein retention as the initiating process in atherosclerosis -: Update and therapeutic implications
Ira Tabas et al.
CIRCULATION (2007)
Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment
Waltraut Ibe et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
F Martinon et al.
MOLECULAR CELL (2002)
Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β
BJ Pomerantz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Pro-inflammatory cytokines in patients with essential hypertension
ACTM Peeters et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
